Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
44 Cards in this Set
- Front
- Back
How much bone marrow is there in the body and where is most of it found?
|
-~3kg in adult male
-Predominantly in pelvis, ribs and long bones |
|
What are the two types of bone marrow and in which does haemopoeisis occur?
|
-Red and yellow marrow
-Haemopoiesis occurs in active red marrow |
|
What is the ratio of red bone marrow to yellow bone marrow? Does this change throughout life?
|
-Red marrow 100% at birth
-Red marrow replaced by inactive yellow marrow (to 50%) increasing with age |
|
What is the structure of bone marrow?
|
-Composed of network of epithelial cell-lined sinusoids interpersed with islands of haemopoietic cells supported by connective tissue elements in the bone marrow stroma (fibroblasts, reticulin, adiposed tissue and endothelial cells)
(diagram) |
|
Define bone marrow failure
|
-Impaired progenitor production of mature cells
-Normal cell morphology and stromal cell function -Stop progress along lineage |
|
What are the 2 types of bone marrow failure? Is the stage in the lineage important?
|
-Pluripotent stem cell failure affects all 3 cell lineages and results in aplastic anaemia
-Committed stem cell failure affects 1 cell lineage and causes single cell deficiency |
|
What is aplastic anaemia?
|
-Pluripotent stem cell failure resulting in pancytopoienia (multicell failure) anaemia (Hb<100g/L), leukopoienia (WCC<4x10^9) and thrombocytopoienia (Plts<100x10^9/L)
-Mechanism is replacement of red marrow with yellow marrow -Diagnosis is based on absence of cells (diagram) |
|
What happens to bone marrow in aplastic anaemia?
|
Red marrow is replaced with yellow marrow (fat)
|
|
What are the types of single cell deficiencies?
|
-Pure red cell aplasia
-Neutropoienia -Amegakaryocytic thrombocytopoienia (diagram) |
|
What is the clinical presentation of bone marrow failure?
|
-Non specific; malaise, fatigue
-Anaemia; dyspnoea, pallor, oedema, palpitations -Neutropenia; infection, fever, mouth ulceration -Thrombocytopenia; bleeding, petechiae, bruising -FBE; dysmorphic features *think of what cell production is inhibited |
|
How often does bone marrow failure occur?
|
Rare, ~1-2 cases/10^6 population per year
|
|
What are the main causes of bone marrow failure?
|
-~60-70% idiopathic causes; ?Genetic predisposition, ?primary haemopoietic stem cell defect, ?secondary to environmental insult on a normal haemopoietic stem cell
-Drugs; anticonvulsants, antithyroid, antibiotics, cytokines -Viruses; hepatitis, EBV, parvovirus -Inherited; Fancomi's anaemia (autosomal recessive) leads to pancytopoienia and Kostmann's syndrome (autosomal recessive) leads to neutropoienia - |
|
What is Myelodysplastic syndrome (MDS)?
|
-Group of disorders arising from an abnormal pluripotent stem cell
-Results in morphological abnormalities in blood and bone marrow -This problem does not stop lineage but just produced mutated cells |
|
What is the clinical presentation of myelodysplastic syndromes (MDS)?
|
-Usually incidental finding (50%)
-Majority present with Macrocytic anaemia, and less commonly with additional cytopoienias or pancytopoienias -Abnormal blood film -Symptoms of bone marrow failure -Rash -Serous effusions -Splenomegaly |
|
How is are myelodysplastic syndromes (MDS) classified?
|
-Morphology
-Depends on; lineage invloved, blast count, presence or absence of ringed siderblasts, precense or absence of a monocytosis & cytogenetics (diagram) |
|
What is the aetiology of myelodysplastic syndrome (MDS)?
|
-Unknown in majority of cases (genetic predisposition may be in younger patients)
-Therapy related (chemotherapy/radiotherapy) |
|
How can myelodysplastic syndrome (MDS) progress to acute myeloid leukaemia?
|
-Increased frequency of cytogenetic abnormalities and molecular lesions targeting tumour supressor genes (oncogenes)
-Clonal evolution can lead to excess proliferation and no differentiation (diagram) |
|
What is the treatment of bone marrow failure and myelodysplastic syndrome (MDS)?
|
-Treatment and prevention of infections
-Treatment and prevention of bleeding complications -Blood product support (RBC, platelets) -Select use of cytokines (EPO;red cells) to increase number of normal cells -Antibiotics -Management of iron overload (iron chelators) |
|
How is haemopoiesis restored after bone marrow failure or myelodysplastic syndrome?
|
-Mild cases may need no specific therapy
-Immunosuppressive therapy targeting t-cell suppression of haemopoeisis (t-cells found to cause suppression of haemopoiesis in infective bone marrow failure); antilymphocyte globulin, cyclosporin, anabolic steroids -Bone marrow transplantation -Selected use of cytokines -Bone marrow transplant |
|
How is the abnormal clone in bone marrow failure or myelodysplastic syndrom eradicated?
|
Chemotherapy (has limitations to effectiveness, risk of prolonged aplasia and difficulties in young and old patients)
-Bone marrow transplantation has potential for cure |
|
How are haematological malignacies classified?
|
-Morphology
-Site (blood/bone marrow=leukaemia v. lymphoid organs=lymphoma) -Course of disease (acute v. chronic) -Cell type (myeloid v. lymphoid v. hairy cell v. myeloma) -Differentiation status (M0-M7(diagram), L1-L3) |
|
What are acute leukemias?
|
-Disorder of stem cell/early progenitor cell
-Increased proliferation and loss of differentiation -Results in accumulation of nonfunctional precursur 'blasts' with organ infiltration -Hypercellular bone marrow with peripheral blood cytopoienias |
|
How do acute leukaemias cause mortality?
|
Due to marrow failure
|
|
How do acute myeloid leukaemias affect other lineages?
|
They crowd out other cell types causing dysfunction
(diagram) |
|
What are the causes of acute leukaemia?
|
-Aetiology unknown however role of cytotoxics and radiation
-?research into genetic causes |
|
What is the treatment principles of acute leukaemia?
|
-Eridicate clone with cytotoxic chemicals and support patient with blood products and antibiotics
-Facilitate differentiation -Low dose chemotherapy |
|
How common are lymphomas as a malignancy in the community?
|
6th most common malignancies in the community (5% and rising)
|
|
In what age are lymphomas most common?
|
Middle life
|
|
What cells are most affected by lymphomas?
|
B cells
|
|
What is hodgkins lymphoma?
|
-Painless lymphadenopathy with variably associated constitutional disturbance (fever, weight loss)
-B cell affected -Diagnosed by lymph node biopsy |
|
What is the cause of hodgkins lymphoma?
|
Unknown, peaks in 20's and 50's (bi-modal)
|
|
What is the treatment for hodgkins lymphoma?
|
Early; radiation
Most; combined chemotherapy and deep xray therapy -Focus on preventing long term morbidity |
|
What is non-hodgkins lymphoma?
|
-Any lymphoma that is not hodgkins lymphoma
-Caused by disorder of precurser B cells, mature B cells, precursor T cells and mature T (and NK cells) |
|
How are non-hodgkins lymphomas classified?
|
-Indolent
-Aggressive -Very aggressive |
|
What is the aetiology of non-hodgkins lymphoma?
|
-Genetic translocations
-Viral (EBV, HIV) -Bacterial (h.pylori) |
|
What are the clinical signs and treatment of indolent non-hodgkins lymphoma?
|
-Signs; lymphadenopathy, cytopoienias and immune dysfunction
-Treatment; monoclonal antibodies, chemotherapy, antibodies |
|
What are the clinical signs and treatment of aggressive/very aggressive non-hodgkins lymphoma?
|
Signs; lymphadenopathy and constitutional disturbance
-Treatment; combination chemotherapy |
|
What are chronic myeloproliferative disorders?
|
-Stem cell disorder
-Increased proliferation and maintenance of differentiation -Results in excess of myeloid cells especially RBC's, platelets and neutrophils -Leads to thrombotic state -Increased cell cycling creates propensity for blastic transformation (more turn over more chance of mistake) |
|
List examples of chronic myeloproliferative disorders
|
-Polycythaemia vera (PV)
-Chronic idiopathic myelofibrosis (with extramedullary haemopoiesis) (IMF) -Essential thrombocythaemia (ET) -Chronic myeloproliferative disease, unclassifiable -Chronic myelogenous leukaemia (CML) -Chronic neutrophilic leukaemia (CNL) -Chronic eosinophilic leukaemia (& hypereosinophilic syndrome) (CEL) |
|
How does polycythaemia vera affect the lineage and production of cells?
|
(diagram)
|
|
How does chronic myeloid leukaemia affect the lineage and production of cells?
|
(diagram)
|
|
What are the causes of myeloproliferative disorders?
|
-PV, IMF, ET; Jak2 kinase mutation(downstream of EpoR+TpoR), TpoR mutation
-Erythrocytosis; EpoR truncation -CML; BCR-ABL translocation t(9,22)(q34,q11) |
|
What are the treatments of myeloproliferative disorders?
|
-Phlebotomy
-Anti-thombolytic agents -If specific cause known; CML-BCR-ABL inhibitor (Gleevac), PV-Jak 2 inhibitor |
|
What is Jak 2?
|
Switch responsible for turning on and off receptors in particular lineages in the presence of soluble factors
|